Prof. S. Marnitz, M.D.

completed her training as a radiation oncologist at the Charité in Berlin and at the UK Essen and worked for many years as a senior physician and senior physician at the Charité. After being called to the Chair of Radiation Therapy at the University Hospital in Cologne, she worked there as Clinic Director until 2022. Prof. Dr.med. S. Marnitz has acquired, managed and published several scientific studies funded by the German Cancer Aid. Scientific and clinical focal points include high-precision therapy, the treatment of gynecological tumors and prostate and breast carcinomas. She is congress president of the annual congress of the German Society for Radiation Oncology (DEGRO) 2024.

Period Content
1997-2001 Training at the Charité Clinic for Radiation Therapy, Berlin
(Prof. Dr. med. Budach)
2002-2004 Training at the Clinic for Radiation Therapy at the University Hospital Essen
(Professor Dr Stuschke)
2004 Board certification Radiation Oncology (Düsseldorf Medical Association)
2004-2007 Senior Physician at the Charité Clinic for Radiation Therapy, locations CBF, CCM and CVK)
2005-2007 Senior Consultant for proton therapy at the Hahn-Meitner Institute in Berlin
2007 Habilitation and Venia Legendi at the Charité in the field of radiation therapy
2007-2015 Senior Physician and Deputy Clinic Director at the Charité Clinic for Radiation Therapy
2011 Appointment to the W2 professorship at the Charité
2015 Call for the Chair of Radiation Therapy at the University of Jena, W3 professorship (rejected)
2015 Call for the Chair of Radiation Therapy at the University of Cologne, W3 professorship
2015-2022 Chair and Clinic Director at the Clinic for Radiation Oncology, CyberKnife and Radiation Therapy at the University Hospital in Cologne
Since 2022 Head of the private practice for radiation oncology in the Voßpalais, Berlin

Memberships/committee work

DEGRO, ARO, DKG, AGO, ESTRO, ESGO
Honorary Member of the Russian Society of Gynaecological Oncology (RSGO)

Member of the interdisciplinary guideline committees:

  • cervical carcinoma,
  • Vulvar and vaginal carcinoma
  • European Guideline Commission for Endometrial Cancer (ESGO/ESTRO)